Wearable Devices Ltd. Ordinary Share (WLDS)

FairStock Score: 45/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach this as a Graham-style asset-and-earnings question, and Wearable Devices gives me very little to underwrite. The business is a 32-employee technology firm selling a non-invasive neural input interface and Mudra development kits for controlling phones, AR/VR headsets, wearables, computers and other devices through finger and hand gestures. The idea addresses large markets, but I see no evidence in the supplied figures of a durable moat—no pricing power, no repeat revenue, no multi-year record. In fact, the Lynch category is none because there are only 0 years of filed results, and we need three. Financial health is poor. The FairStock-calculated P/E is -0.03 as of the 2026-10-13 close, so there are no positive earnings to value. FairStock-calculated ROE is -88.65% and ROCE is -52.59%. FairStock's Piotroski F-Score is 1/9 and its Altman Z-Score is 0.85, which points to distress. Debt is low—D/E 0.01—so leverage is not the immediate problem; the problem is profitability and scale. Valuation is curious: P/B is 0.07, so the market cap of $6.8M is a tiny fraction of book value by FairStock's calculation. That could mean assets are undervalued, or it could mean the book value is not worth much in cash terms. The stock is volatile: beta 2.97 and a 52-week range of $0.63 to $11.76. With no revenue or profit growth figures filed, I cannot trace a growth trajectory. At $1.42, this is a speculative asset play, not a proven compounder. I would need years of filed results and evidence of commercial traction before calling it a business rather than a promise.

In plain English: Wearable Devices makes a non-invasive neural input interface and Mudra development kits that let people control devices with finger movements and hand gestures. The business looks very weak today: it is losing money, has a short reporting history, and scores poorly on financial health. The price looks very low compared with its accounting value, but there is no real earnings track record to judge it by.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer